Dr. Alessandro Vindigni named the Ira Lang Professor of Medicine

Dr. Alessandro Vindigni named the Ira Lang Professor of Medicine
Dr. Vindigni is the Director of the Center for Genome Integrity and serves as co-leader of the Section of Molecular Oncology in the Division of Oncology. Dr. Vindigni is internationally recognized for his work on DNA replication. He leads one of the few laboratories in the world that integrates electron microscopy approaches with genome-wide single-molecule DNA […]

Research Symposium to Honor John DiPersio’s Contributions to the Study of Hematologic Malignancies

Research Symposium to Honor John DiPersio’s Contributions to the Study of Hematologic Malignancies
The John F. DiPersio Immunotherapy Symposium will take place on Wednesday March 27, 2024. The symposium honors John DiPersio’s contributions to the understanding of the pathogenesis of and development of new treatments for hematopoietic malignancies.   The symposium will feature presentations by three leaders in the field of cancer immunotherapy.  Dr. Stanley Riddell (Fred Hutchinson […]

Dr. David DeNardo Explores How the Tumor Microenvironment Affects Immune Responses to Cancer (Links to an external site)

Dr. David DeNardo Explores How the Tumor Microenvironment Affects Immune Responses to Cancer
David DeNardo, Ph.D., is a Professor of Medicine in the Division of Oncology and Co-Director of the Tumor Immunology Program. His work on responses to cancer immunotherapy was recently highlighted on the NCI website. His research team is working to understand why responses to cancer immunotherapy vary among patients. In studying and uncovering mechanisms of […]

Maria Baggstrom Awarded Fellow of the American Society of Clinical Oncology Distinction (Links to an external site)

Maria Baggstrom Awarded Fellow of the American Society of Clinical Oncology Distinction
Dr. Baggstrom is an ASCO Education Scholar, an associate editor on ASCO’s digital education editorial board, and has served as chair of the organization’s membership advisory committee and on the steering committee of ASCO’s DEI efforts for rising second-year URiM medical students.  The FASCO distinction recognizes members for their extraordinary volunteer service, engagement, dedication, and […]

Dr. Thomas Odeny Receives Winn Career Development Award (Links to an external site)

Dr. Thomas Odeny Receives Winn Career Development Award
Thomas Odeny, Assistant Professor of Medicine leads the Global Oncology Program in the Division of Oncology. He is the one of the scholars to receive a Robert A. Winn Diversity in Clinical Trials Award. His clinical research grant focuses on expanding clinical trials and treatment options for cancer in underrepresented people living with HIV in […]

Dr. John DiPersio Selected to Give the Prestigious E. Donnall Thomas Lecture (Links to an external site)

Dr. John DiPersio Selected to Give the Prestigious E. Donnall Thomas Lecture
John DiPersio, MD, PhD, Professor Medicine in the Division of Oncology will give the 2024 E Donnall Thomas lecture at the ASTCT/CIBMTR Tandem Meetings in San Antonio. The E. Donnall Thomas Lecture recognizes an eminent physician or scientist, either a clinician or an investigator, who has contributed meritoriously to the advancement of knowledge in blood […]

Oncology Faculty Members Receive Siteman Investment Program Research Grants

Oncology Faculty Members Receive Siteman Investment Program Research Grants
Melissa Reimers, Nikolaos Trikalinos, Kian-Huat Lim, Milan Chheda and Christopher Maher from the Division of Oncology received Siteman Investment Program funding for their research. Dr. Reimers, Associate Professor of Medicine, will assess the safety and tolerability of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat diabetes and heart failure, in patients with high-risk […]

Phase 3 Trial in Breast Cancer Published in JAMA Oncology (Links to an external site)

Phase 3 Trial in Breast Cancer Published in JAMA Oncology
Cynthia Ma , lead author and Professor of Medicine in the Division of Oncology along with her colleagues Kiran Vij, Jeremy Hoog, Mark Watson and Erika Crouch in the Department of Pathology investigated the role of neoadjuvant anastrazole, fulvestrant or the combination in a multi-institutional trial. The trial did not find a benefit of fulvestrant […]